Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. AXS
AXS logo

AXS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy AXIS Capital Holdings Ltd (AXS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
100.610
1 Day change
0.76%
52 Week Range
110.340
Analysis Updated At
2026/03/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Axis Capital Holdings Ltd (AXS) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. While the company shows positive financial performance and analyst sentiment, the lack of strong proprietary trading signals, insider and hedge fund selling, and a neutral technical setup suggest holding off on immediate investment.

Technical Analysis

The MACD is slightly positive but contracting, RSI is neutral at 44.107, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading below the pivot level of 104.259, with support at 101.894 and resistance at 106.624. This indicates a neutral to slightly bearish short-term outlook.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
6

Positive Catalysts

  • Analysts have raised price targets, with multiple firms maintaining Buy or Outperform ratings.

  • Strong Q4 2025 financial performance, with revenue up 17.32% YoY and EPS up 8.58%.

  • Dividend yield of 1.68% and a recent dividend declaration of $0.44 per share.

  • Anticipated mid- to high single-digit premium growth for 2026.

Neutral/Negative Catalysts

  • Hedge funds and insiders are selling significantly, with hedge fund selling up 920.02% and insider selling up 19,913.40%.

  • Analysts note a softening P&C insurance market, which could pressure growth and margins.

  • Stock trend analysis indicates a potential short-term decline, with a 20% chance of a -4.42% drop in the next week.

Financial Performance

In Q4 2025, revenue increased by 17.32% YoY to $1.73 billion, EPS rose by 8.58% YoY to $3.67, but net income dropped slightly by -1.41% YoY to $282.05 million. The company beat EPS and revenue expectations, driven by lower catastrophe losses and favorable loss reserve development.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive, with price targets ranging from $110 to $141. Most firms maintain Buy or Outperform ratings, citing strong underwriting performance, premium growth, and potential for multiple expansion. However, some concerns about market softening and lower EPS growth relative to peers were noted.

Wall Street analysts forecast AXS stock price to rise
9 Analyst Rating
Wall Street analysts forecast AXS stock price to rise
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 99.850
sliders
Low
110
Averages
124.22
High
141
Current: 99.850
sliders
Low
110
Averages
124.22
High
141
Mizuho
Outperform
maintain
$133 -> $141
AI Analysis
2026-02-02
Reason
Mizuho
Price Target
$133 -> $141
AI Analysis
2026-02-02
maintain
Outperform
Reason
Mizuho raised the firm's price target on Axis Capital to $141 from $133 and keeps an Outperform rating on the shares. The firm says the company ended 2025 with "nice momentum." Axis is seeing accelerating premium growth and underlying loss ratio stability, the analyst tells investors in a research note.
UBS
Brian Meredith
Buy
maintain
$126 -> $129
2026-02-02
Reason
UBS
Brian Meredith
Price Target
$126 -> $129
2026-02-02
maintain
Buy
Reason
UBS analyst Brian Meredith raised the firm's price target on Axis Capital to $129 from $126 and keeps a Buy rating on the shares. Insurance brokers are well positioned for 2026, with organic revenue growth averaging 4.4% and EBITDA margins improving year over year despite property rate pressures, the analyst tells investors in a research note. With growth expectations reset and valuations reflecting a softer market, there is upside to consensus EPS and potential for multiple expansion, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AXS
Unlock Now

People Also Watch